Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Licensed clinician review
A small observational study published in JCI Insight (2022) examined individuals with obesity receiving semaglutide who reported reductions in alcohol intake, though the relationship to weight loss requires further investigation in controlled trials
Rigorous integration therefore requires method selection aligned with study structure, transparent handling of batch effects and missingness mechanisms, and validation strategies anchored to patient-relevant outcomes rather than intermediate surrogates
See our Research Use Only policy
US$ 24.46
US$ 24.01
US$ 24.47
US$ 22.89
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 24.89
US$ 22.27
